Plasmacytoid Dendritic Cell Function and Cytokine Network Profiles in Patients with Acute or Chronic Hepatitis B Virus Infection-Reference-Cited by-同舟云学术

Plasmacytoid Dendritic Cell Function and Cytokine Network Profiles in Patients with Acute or Chronic Hepatitis B Virus Infection

Published:2018-01-05 Issue:1 Volume:131 Page:43-49
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Li Ming-Hui,Zhang Lu,Zhang Dan,Cao Wei-Hua,Qi Tian-Lin,Hao Hong-Xiao,Wang Xing-Yue,Ran Chong-Ping,Qu Xiao-Jing,Liu Shun-Ai,Lu Yao,Shen Ge,Wu Shu-Ling,Chang Min,Liu Ru-Yu,Hu Lei-Ping,Hua Wen-Hao,Wan Gang,Cheng Jun,Xie Yao

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference45 articles.

1. Hepatitis B e-antigen persistency is associated with the properties of HBV-specific CD8 T cells in CHB patients;Peng;J Clin Immunol,2011

2. Altered functions of plasmacytoid dendritic cells and reduced cytolytic activity of natural killer cells in patients with chronic HBV infection;Martinet;Gastroenterology,2012

3. Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function;Woltman;PLoS One,2011

4. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B;van der Molen;Hepatology,2004

5. Impaired functional capacities of liver dendritic cells from murine hepatitis B virus (HBV) carriers: Relevance to low HBV-specific immune responses;Hasebe;Clin Exp Immunol,2005

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into Immune Exhaustion in Chronic Hepatitis B: A Review of Checkpoint Receptor Expression;Pharmaceuticals;2024-07-21

2. Dendritic cell‐based immunotherapy: A potential therapeutic option for chronic Hepatitis B virus infection;Clinical and Translational Discovery;2023-02

3. Clinical Factors Affecting Platelet Growth in the Treatment of Aplastic Anemia by Tonifying Kidney and Generating Blood;World Journal of Traditional Chinese Medicine;2023

4. Sustained viral response and relapse after discontinuation of oral antiviral drugs in HBeAg-positive patients with chronic hepatitis B infection;Frontiers in Immunology;2022-11-25

5. Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B;Frontiers in Immunology;2022-09-20